FDA Inspection
Mitsubishi Tanabe Pharma Development America, Inc.Mitsubishi Tanabe Pharma Development America, Inc. – FDA Inspection, Dec 4, 2013
Record Details
This FDA Inspection record concerns Mitsubishi Tanabe Pharma Development America, Inc., with an inspection on December 4, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- December 4, 2013
- Product Type
- Drugs
View Company Profile
ID · 24eb30a9-ccc6-44e7-bcfa-9e1a8da6556c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 857641
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.50General responsibilities of sponsors
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Mitsubishi Tanabe Pharma Development America, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 18, 2025 | Not classified | New Jersey District Office | |
| October 15, 2021 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Mitsubishi Tanabe Pharma Development America, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.